The Ace Avanteon Study - A Randomized Controled Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-80
SponsorHelse Møre og Romsdal HF

About this trial

The goal of this randomized controled trial is to compare if using of ancillary screws yields equal results as no use of ancillary screws in the ACE acetabulum cup of a total hip arthroplasty. Further, the migration of the Avanteon stem over time will be assessed. Patients included are patients with hip osteoarthritis from 65-80 years old. The purpose of this study is to compare implant migration and early fixation of a hybrid hip replacement combining the uncemented ACE acetabular component and the cemented Avanteon femoral stem, by using CT based Radiostereometric Analysis, a new innovative method for evaluating implant migration. Our study may predict the long term survival of the implants used.

Participants will go through total hip arthroplasty, and be followed by CT-RSA, plain x-rays and patients reported outcome measures.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

• Patients with primary hip osteoarthritis between the age of 65 and 80 years at time of surgery

Patients requiring primary total hip replacement

Patients who understand the conditions of the study, are willing to, and able to comply with the postoperative scheduled clinical and radiographic evaluations

Disqualifiers

• Patients who are unable to provide informed consent

Patients who require revision hip arthroplasty

Patients who have had a previous osteotomy or osteosynthesis of the femur or acetabulum

Patients with metabolic bone disease, other than osteoporosis

Trial design

Design model

Parallel

Treatments tested in this trial

  • Total Hip Arthroplasty

    Procedure/Surgery

    Surgery for total hip replacement

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Ancillary screw groupExperimental treatment 1 intervention
Group B: Without ancillary screws groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Translation

Proximal Y migration acetabular cup measured by CT-RSA

Time frame
2 years

Secondary outcomes

1

Rotation

Rotation XYZ measured by CT-RSA

Time frame
2 years
2

Migration

Anterior and axial XZ migration acetabular cup measured by CT-RSA

Time frame
2 years
3

MTPM

MTPM of acetabular cup

Time frame
2 years
4

Stem Tr

Subsidence of stem

Time frame
2 years

Other outcomes

1

Difference precision

Precision CT-RSA measured by double investigations at 2 different dose levels

Time frame
3 months
2

PROMs

Patient reported outcome measures like EQ-5D-5L, OHS, VAS, FJS and HOOS

Time frame
2 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Helse Møre og Romsdal HF

Lead sponsor

St. Olavs Hospital

Collaborator

JRI Orthopaedics Ltd

Collaborator